Menu
GeneBe

rs1555876140

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_003073.5(SMARCB1):c.351del(p.Thr118ProfsTer25) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. P116P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)

Consequence

SMARCB1
NM_003073.5 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 7.91
Variant links:
Genes affected
SMARCB1 (HGNC:11103): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1) The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-23793671-GC-G is Pathogenic according to our data. Variant chr22-23793671-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 692027.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr22-23793671-GC-G is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMARCB1NM_003073.5 linkuse as main transcriptc.351del p.Thr118ProfsTer25 frameshift_variant 3/9 ENST00000644036.2
SMARCB1NM_001362877.2 linkuse as main transcriptc.351del p.Thr118ProfsTer25 frameshift_variant 3/9
SMARCB1NM_001317946.2 linkuse as main transcriptc.324del p.Thr109ProfsTer25 frameshift_variant 3/9
SMARCB1NM_001007468.3 linkuse as main transcriptc.324del p.Thr109ProfsTer25 frameshift_variant 3/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMARCB1ENST00000644036.2 linkuse as main transcriptc.351del p.Thr118ProfsTer25 frameshift_variant 3/9 NM_003073.5 A1Q12824-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Teratoid tumor, atypical Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingRady Children's Institute for Genomic Medicine, Rady Children's Hospital San DiegoMay 03, 2018This variant has not been previously reported or functionally characterized in the literature to our knowledge. However, pathogenic variation in SMARCB1 has been associated with Coffin-Siris syndrome 3 (MIM: 614608), rhabdoid tumor predisposition syndrome 1 (MIM: 609322), and susceptibility to schwannomatosis-1 (MIM: 162091). In particular, null variants are generally associated with rhabdoid tumors, while missense variants tend to be associated with Coffin-Siris syndrome 3 and familial schwannomatosis. This particular null variant has not been reported in affected individuals in ClinVar or HGMD, and this variant has not been observed in the gnomAD population database. This variant is predicted to result in a frameshift (in exon 3 of 9) and a premature STOP codon after 27 additional amino acids, leading to the production of truncated SMARCB1 protein likely with little or no functional activity. An additional somatic mutation in the remaining normal copy of the SMARCB1 gene would result in the development of rhabdoid tumors. Based on the combined evidence, the c.347_348delinsT Pro116Leufs*27 variant is classified as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1555876140; hg19: chr22-24135858; API